Pages
Subscribe to my blog
-
Recent Blog Posts
- Resignation from TGACC
- Independent Review of the Therapeutic Goods Advertising Framework: Recommendations
- Complementary medicine weight loss products complaints submitted to the TGA in 2018-2019. Follow-up.
- Towards independence from commercial interests in health
- TGA stakeholder survey 2019
- The TGA and COVID-19: Starting to use its compliance teeth!
Themes
- ABC
- ACCC
- advertisments
- AHPRA
- AMHC
- AMI
- Blackmores
- Chiropractic Board
- Complaint Resolution Panel
- consumers
- CRP
- Dr Jacqui Forrester
- Dr Tom Goyer
- food-medicine interface
- Friends of Science in Medicine
- FSANZ
- FSM
- Geoff Jowett
- Health Practitioner Regulation National Law Act
- health professionals
- homeopathic medicines
- Ian Rossborough
- La Trobe University
- Medical Weightloss Institute
- Medicines Australia
- MMD Review
- Monash University
- MWI
- Pharmacare Laboratories
- promotion
- Regulatory Reform
- self-regulation
- Senate Community Affairs Legislation Committee
- Souvenaid
- Swisse
- Swisse Vitamins
- TGA
- TGACC
- TGA Complaint system
- TGACRP
- Therapeutic Goods Act
- Therapeutic Goods Advertising Code
- Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017
- Transparency
- U3A
Archives
- November 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- October 2019
- September 2019
- August 2019
- July 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- January 2015
- December 2014
- November 2014
- October 2014
- July 2014
- March 2014
- February 2014
- January 2014
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- August 2012
- July 2012
- May 2012
- April 2012
- March 2012
- June 2011
Subscribe2
Tag Archives: Medicines Australia
Medicines Australia Transparency Working Group Releases Reports
The documents, “Principles for transparency” and “Transparency model consultation and discussion document” are now available. For comment see: Harvey K. Slow path to transparency. MJA Insight, July 1, 2013. https://www.mja.com.au/insight/2013/24/ken-harvey-slow-path-transparency Coleman J. GPs will gain from greater transparency. 6 Minutes Q&A, July … Continue reading
Transcripts now available: Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013
See: Finance and Public Administration Legislation Committee; Monday, 29 April 2013 by
Posted in Pharmaceutical Promotion, Senate
Tagged Medicines Australia, self-regulation
Leave a comment
Melbourne Senate Public Hearing: Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013
On Monday, April 29, 2013 I’m appearing before a Senate committee to give evidence about this bill put up by Greens Senator Richard Di Natale. The committee is looking at the need for regulation of pharmaceutical industry conduct with regards to interactions with the … Continue reading
Posted in Pharmaceutical Promotion, Senate
Tagged Medicines Australia, self-regulation
Leave a comment
Submission re Senate Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013
Now posted on the Senate web site along with others. Today is the last day for submissions so I guess more will show up next week. by
Posted in Pharmaceutical Promotion, Senate
Tagged Medicines Australia, self-regulation
Leave a comment
Gave talk to ARCS Melbourne Regional Networking Group,
Self-regulation versus co-regulation: A consumer perspective. Noted that submissions to Greens Senator Di Natale Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013 should be lodged by 19 April 2013 to the Finance and Public Administration Legislation Committee. Reiterated that legislation is required to make compliance … Continue reading
Posted in Pharmaceutical Promotion, Senate
Tagged Medicines Australia, Regulatory Reform, self-regulation
Leave a comment
Published comment on MJA Insight: Vital transparency
http://www.mjainsight.com.au/view?post=ken-harvey-vital-transparency&post_id=11651&cat=comment FULL disclosure of the relationship between therapeutic goods companies, doctors and other stakeholders is currently in the hands of the Australian Competition and Consumer Commission. The ACCC is currently deciding if it will give the go-ahead to the 17th … Continue reading
Australian Skeptic National Convention December 1-2, 2012
I was delighted to be able to contribute to this excellent program: In a panel discussion with colleagues, “Active Skepticism: An Evidence-Based Approach to Medical Treatment” and A talk titled, “Confessions of a Serial Complainant: Why Take On the Therapeutic … Continue reading
ACCC Pre-decision conference: Medicines Australia Code
At yesterday’s meeting with the ACCC, Ian Haines, Bob Arnold, Carol Bennett, Ray Moynihan and I argued that full disclosure of the relationship between therapeutic goods companies, physicians and other stakeholders is crucial. I tabled a petition that currently has … Continue reading
Petition to ACCC on Medicines Australia Code Authorisation
While collaborations between industry and health professionals are desirable, widespread financial ties bring significant risks of undue influence on professional judgements, potentially jeopardizing the integrity of medical research, education, clinical practice and public trust in medicine, according to a landmark … Continue reading
ACCC now posting submissions on Medicines Australia Code
See: http://www.accc.gov.au/content/index.phtml/itemId/1063694/fromItemId/278039/display/submission The AMA’s submission to the ACCC is also available at: http://ama.com.au/print/8101 “The AMA therefore commends Medicines Australia’s proposal to work further with stakeholders on the issue of public reporting on pharmaceutical companies interactions with individual healthcare professionals”. Reminiscent … Continue reading
Posted in Pharmaceutical Promotion
Tagged AMA, Code authorisation, Medicines Australia
Leave a comment